Opioids for management of endometriosis associated pain: balancing effectiveness and quality of life

To identify risk factors for opioid use and assess the effect of opioids on women with endometriosis. A retrospective cohort study. A tertiary medical center. Women with confirmed or suspected endometriosis aged 18–45 years. Recruited participants completed a questionnaire including baseline demographic and general health data, a Brief Pain Inventory (BPI-Heb) and a Visual Analogue Scale assessing Endometriosis associated pain symptoms. Women using opioids were compared to women not using opioids. Women treated with opioids further completed a Visual Analogue Scale quesionniare of pain symptoms after using opioids, a questionnaire assessing side effects, and the Opioid Risk Tool for the assessment of addiction risk. Ninety-eight patients were included in the study. Of them, 49 were opioid users, and 49 were non-opioid users. One unit increase in overall pain was associated with a 28% increased risk of opioid use [OR = 1.28, 95% CI 1.1–1.5, p = .007]. Use of hormonal therapy and smoking also increased opioid use risk [OR = 6.16, 95% CI 1.7–22.5, p = 0.006, OR = 4.36, 95% CI 1.2–16.1, p = .027, respectively]. Within the opioid users group, all pain symptoms and quality of life domains were significantly improved, with the most significant improvement demonstrated in dysmenorrhea and sleeping quality (median change: -4.5 (p < .001) and 5 (p < .001) points, respectively). While there were no life-threatening side effects, 94% of women using opioids experienced at least one side effect and 33% had moderate to high risk of addiction. In our study, the risk of opioid use among women with endometriosis was increased for women with hormonal therapy, smoking and higher pain severity. While opioids were associated with high rates of side effects, they were effective pain relievers and overall quality of life was improved. More research is needed to delineate better the role and risks of opioids for the treatment of endometriosis associated pain.

Authors

Institutions

Publication Details

Journal
BMC Women s Health
Published
2026-04-06
DOI
https://doi.org/10.1186/s12905-026-04423-0
Primary Topic
Endometriosis Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Opioids for management of endometriosis associated pain: balancing effectiveness and quality of life

Uri P. Dior, Nir Cohen, Ilan Matok, Tal D. Saar et al.
BMC Women s Health
Endometriosis Research and Treatment
article

Opioids for management of endometriosis associated pain: balancing effectiveness and quality of life

Uri P. Dior, Nir Cohen, Ilan Matok, Tal D. Saar, Yael Roza Douak
article en

Abstract

To identify risk factors for opioid use and assess the effect of opioids on women with endometriosis. A retrospective cohort study. A tertiary medical center. Women with confirmed or suspected endometriosis aged 18–45 years. Recruited participants completed a questionnaire including baseline demographic and general health data, a Brief Pain Inventory (BPI-Heb) and a Visual Analogue Scale assessing Endometriosis associated pain symptoms. Women using opioids were compared to women not using opioids. Women treated with opioids further completed a Visual Analogue Scale quesionniare of pain symptoms after using opioids, a questionnaire assessing side effects, and the Opioid Risk Tool for the assessment of addiction risk. Ninety-eight patients were included in the study. Of them, 49 were opioid users, and 49 were non-opioid users. One unit increase in overall pain was associated with a 28% increased risk of opioid use [OR = 1.28, 95% CI 1.1–1.5, p = .007]. Use of hormonal therapy and smoking also increased opioid use risk [OR = 6.16, 95% CI 1.7–22.5, p = 0.006, OR = 4.36, 95% CI 1.2–16.1, p = .027, respectively]. Within the opioid users group, all pain symptoms and quality of life domains were significantly improved, with the most significant improvement demonstrated in dysmenorrhea and sleeping quality (median change: -4.5 (p < .001) and 5 (p < .001) points, respectively). While there were no life-threatening side effects, 94% of women using opioids experienced at least one side effect and 33% had moderate to high risk of addiction. In our study, the risk of opioid use among women with endometriosis was increased for women with hormonal therapy, smoking and higher pain severity. While opioids were associated with high rates of side effects, they were effective pain relievers and overall quality of life was improved. More research is needed to delineate better the role and risks of opioids for the treatment of endometriosis associated pain.

BMC Women s Health
Hebrew University of Jerusalem (IL), Hadassah Medical Center (IL)
Good health and well-being
Openalex Percentile: Top 27%
Endometriosis Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.